# A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

> **NCT07662122** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 344 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** BI 3034701
- **DRUG:** Placebo matching BI 3034701

## Key facts

- **NCT ID:** NCT07662122
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2027-06-26
- **Final completion:** 2027-07-10
- **Target enrollment:** 344 (ACTUAL)
- **Last updated:** 2026-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07662122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07662122, "A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07662122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*